These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 33514790)

  • 1. LC-MS based case-by-case analysis of the impact of acidic and basic charge variants of bevacizumab on stability and biological activity.
    Singh SK; Kumar D; Malani H; Rathore AS
    Sci Rep; 2021 Jan; 11(1):2487. PubMed ID: 33514790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Similarity demonstrated between isolated charge variants of MB02, a biosimilar of bevacizumab, and Avastin® following extended physicochemical and functional characterization.
    Ruppen I; Beydon ME; Solís C; Sacristán D; Vandenheede I; Ortiz A; Sandra K; Adhikary L
    Biologicals; 2022 Jun; 77():1-15. PubMed ID: 35667958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid characterization of structural and functional similarity for a candidate bevacizumab (Avastin) biosimilar using a multipronged mass-spectrometry-based approach.
    Brown KA; Rajendran S; Dowd J; Wilson DJ
    Drug Test Anal; 2019 Aug; 11(8):1207-1217. PubMed ID: 31041833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biophysical study of bevacizumab structure and bioactivity under thermal and pH-stresses.
    Sousa F; Sarmento B; Neves-Petersen MT
    Eur J Pharm Sci; 2017 Jul; 105():127-136. PubMed ID: 28502677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Similarity demonstrated between isolated charge variants of MB02, a biosimilar of bevacizumab, and Avastin® following extended physicochemical and functional characterization.
    Ruppen I; Beydon ME; Solís C; Sacristán D; Vandenheede I; Ortiz A; Sandra K; Adhikary L
    Biologicals; 2021 Sep; 73():41-56. PubMed ID: 34593306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In-depth size and charge variants characterization of monoclonal antibody with native mass spectrometry.
    Dai J; Ji C
    Anal Chim Acta; 2023 Jul; 1265():341360. PubMed ID: 37230578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation and characterization of charge variants of infliximab biosimilar HS626.
    Yuan JJ; Gao D; Hu F; Shi Y; Wu ZH; Hu CQ; Huang XD; Fang WJ; Zhang HT; Wang HB
    J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Jan; 1162():122485. PubMed ID: 33360415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural and Functional Analysis of CEX Fractions Collected from a Novel Avastin
    Gurel B; Berksoz M; Capkin E; Parlar A; Pala MC; Ozkan A; Capan Y; Daglikoca DE; Yuce M
    Pharmaceutics; 2022 Jul; 14(8):. PubMed ID: 36015197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous Monitoring of Monoclonal Antibody Variants by Strong Cation-Exchange Chromatography Hyphenated to Mass Spectrometry to Assess Quality Attributes of Rituximab-Based Biotherapeutics.
    Di Marco F; Berger T; Esser-Skala W; Rapp E; Regl C; Huber CG
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Charge Variants of an Avastin Biosimilar Isolation, Characterization, In Vitro Properties and Pharmacokinetics in Rat.
    Zhao YY; Wang N; Liu WH; Tao WJ; Liu LL; Shen ZD
    PLoS One; 2016; 11(3):e0151874. PubMed ID: 26987122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiattribute Monitoring of Antibody Charge Variants by Cation-Exchange Chromatography Coupled to Native Mass Spectrometry.
    Haberger M; Heidenreich AK; Hook M; Fichtl J; Lang R; Cymer F; Adibzadeh M; Kuhne F; Wegele H; Reusch D; Bonnington L; Bulau P
    J Am Soc Mass Spectrom; 2021 Aug; 32(8):2062-2071. PubMed ID: 33687195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonclinical assessments of the potential biosimilar PF-06439535 and bevacizumab.
    Peraza MA; Rule KE; Shiue MHI; Finch GL; Thibault S; Brown PR; Clarke DW; Leach MW
    Regul Toxicol Pharmacol; 2018 Jun; 95():236-243. PubMed ID: 29574193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Charge Variant of Bevacizumab Offers Enhanced FcRn-Dependent Pharmacokinetic Half-Life and Efficacy.
    Singh SK; Kumar D; Nagpal S; Dubey SK; Rathore AS
    Pharm Res; 2022 May; 39(5):851-865. PubMed ID: 35355206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microfluidic capillary electrophoresis - mass spectrometry for rapid charge-variant and glycoform assessment of monoclonal antibody biosimilar candidates.
    Cageling R; Carillo S; Boumeester AJ; Lubbers-Geuijen K; Bones J; Jooß K; Somsen GW
    J Pharm Biomed Anal; 2024 Sep; 248():116301. PubMed ID: 38901155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of therapeutic proteins by cation exchange chromatography-mass spectrometry and top-down analysis.
    Shi RL; Xiao G; Dillon TM; Ricci MS; Bondarenko PV
    MAbs; 2020; 12(1):1739825. PubMed ID: 32292112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of change in the basic variants composition of trastuzumab during dilution in saline for administration.
    Gupta S; Schöneich C; Rathore AS
    Eur J Pharm Biopharm; 2024 Jun; 199():114295. PubMed ID: 38636881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Part 2: Physicochemical characterization of bevacizumab in 2 mg/mL antibody solutions as used in human i.v. administration: Comparison of originator with a biosimilar candidate.
    Arvinte T; Palais C; Poirier E; Cudd A; Rajendran S; Brokx S; Dowd J
    J Pharm Biomed Anal; 2019 Nov; 176():112802. PubMed ID: 31446298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of Recombinant Monoclonal Antibody Charge Variants Using OFFGEL Fractionation, Weak Anion Exchange Chromatography, and Mass Spectrometry.
    Neill A; Nowak C; Patel R; Ponniah G; Gonzalez N; Miano D; Liu H
    Anal Chem; 2015 Jun; 87(12):6204-11. PubMed ID: 25977987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insights into the generation of monoclonal antibody acidic charge variants during Chinese hamster ovary cell cultures.
    Tang H; Miao S; Zhang X; Fan L; Liu X; Tan WS; Zhao L
    Appl Microbiol Biotechnol; 2018 Feb; 102(3):1203-1214. PubMed ID: 29238873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of structural and functional similarity of biosimilar products: Bevacizumab as a case study.
    Bhattacharya S; Rathore AS
    J Chromatogr B Analyt Technol Biomed Life Sci; 2023 Sep; 1229():123896. PubMed ID: 37776677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.